Thursday, 12 January 2017

Fusion Protein, CGEN-15001, Shows Ability to Restore Immune Balance in Mice with MS


Compugen has reported new and promising results from studies on animal models of multiple sclerosis (MS) that support its lead drug candidate, CGEN-15001, as a potential treatment for a variety of autoimmune diseases, including MS.  Read on.